Putting Phytoremediation into Action

Researchers studying the use of bacteria and plants to remove toxins from the soil must better communicate their results if they want their techniques to be used by practitioners in the field.

Written byÉric Montpetit and Erick Lachapelle
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

GREEN CLEAN MACHINES: A site near the city of Varennes, Quebec, where researchers on the Genome Canada project tested the efficacy of various willow cultivars to remediate soil polluted by petroleum hydrocarbons PHOTO COURTESY OF MICHEL LABRECQUE

Despite the enactment of comprehensive regulations, soil contamination remains widespread in much of the industrialized world. Researchers have estimated there are more than 160,000 sites in Western Europe alone that contain pollutants at levels above acceptable thresholds (J Environ Public Health, 2013: 158764, 2013), and the problem is just as significant in the United States (Environ Sci Technol, 39:5567-74, 2005). Owing to the cost of ex situ remediation, many contaminated sites are left untreated, allowing toxic chemicals to leach into nearby ground or surface waters and be taken up by plants and animals. Ultimately, soil contamination poses substantial risks for human health, and much work remains to significantly remediate lands that are known to be contaminated. (See “Drugging the Environment” here.)

Over the past 20 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies